EMERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCall/ — Bionovo, Inc. announced the company will present results from the Phase 1B clinical trial of their lead drug candidate for advanced metastatic breast cancer, BZL101, at the Society for…
View original post here:
Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.